Obstructive Sleep Apnea as a Potential Risk Factor for COVID-19: Expert Interview
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Melatonin and other melatonin receptor agonists have demonstrated efficacy in the treatment of circadian rhythm disorders in both pediatric and adult populations.
Accumulating evidence suggests that COVID-19 can lead to neurological complications.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.
Although associations between migraine headaches and CVD have been known for more than 40 years, the underlying pathobiology of this connection has not been appreciated until recently.
Atrial fibrillation, which affects up to 46.3 million people globally and 2.7 to 6.1 million individuals in the US, may represent a modifiable risk factor for acute stroke.